LEP and breast carcinoma: Notably, leptin has been shown to increase protein levels of TGFβ1 in ER + and ER- breast cancer cells (MCF7, MCF10AT1) and a neutralising antibody against TGFβ1 blocks leptin-mediated actions [129].